At an AdvaMed-sponsoered event at the OneMed conference in San Francisco, Covidien CEO Joe Almeida described emerging markets as a "great attraction" for medical device companies. He, however, stressed the importance of knowing "where you are going to play in those markets. Being global doesn’t mean being all over the place," he said. "You have got have a concerted effort."

Such an effort requires a careful study of, for instance, what kind of business your firm plans on running abroad. If your firm plans on doing business in, for instance, China, carefully consider the type of hospital in which your products will be used. The type of hospital and city your products are used in has "huge implications." 

When doing business in emerging markets, medtech firms should also make sure that...

January 19th, 2012
0

David DykemanMD+DI has three new features dedicated to intellectual property. The first new feature is the first in a series on the impact of patent reform on medical device entrepreneurs. The first installment, titled "What Medtech Entrepreneurs Need to Know about Patent Reform," is a question and answer session with David Dykeman (pictured on the right), patent attorney and co-chair of the IP department at Greenberg Traurig LLP. The second installment is titled "What You Should Know about Patent Reform: The Post-Grant Review Process."

A second feature, titled "...

January 19th, 2012
0

The Dr. Paul Janssen Award Selection Committee is now seeking nominations of deserving individuals or a group of individuals for the 2012 Dr. Paul Janssen Award for Biomedical Research. Those interested in nominating a scientist can make a submission here.

Nominations will be accepted until February 15, 2012, and the Award will be presented in September 2012.

Each year, Johnson & Johnson awards the Dr. Paul Janssen Award to a deserving individual or group of individuals whose achievements in the field of biomedicine or medical technology have made, or have strong potential to make, a measurable impact on human health. The Award  includes a citation and prize of $100,000.  Past...

January 19th, 2012
0

In February, medical device industry professionals will gather in Anaheim, CA, for the 2012 Medical Design & Manufacturing (MD&M) West trade show event. Featuring an exposition and conference, MD&M West brings together medical device manufacturers, suppliers, and industry experts for three days of networking and education at the Anaheim Convention Center. 

The two-day expo will feature qualified suppliers showcasing all the products and services OEMs need to develop innovative medical devices. Attendees can browse exhibits featuring everything from materials to components to design services. As an added bonus, an MD&M badge also gets attendees access to eight other colocated events: Electronics West, West Pack, Pacific Design & Manufacturing, Automation Technology Expo West, Sensor Tec, PlasTec West, AeroCon...

January 19th, 2012
0

In December, 2011, I had a conversation with medtech pioneer Mir Imran, who explained the importance of thoroughly studying a problem in the process of innovation.

Over on MedSider, Arlen Meyers, MD, who is president and CEO of Society of Physician Entrepreneurs, echoes that advice, recommending that entrepreneurs become "problem seekers" instead of "problem solvers."

In that interview, Meyers also explains that “no one knows the [medical device] market better than the doctors.”

It is certainly true that doctors have an advantage here. For instance, one area that physician inventors are noticing is the obesity...

January 18th, 2012
0

Very interesting post from Roger Ehrenberg over at MedCity News. He advises device makers to embrace the tactics opponents to the SOPA (Stop Online Privacy Act) have successfully used and apply them to battling the device tax.
Key actions that have worked for anti-privacy have been to get social and raise awareness, align with innovation, make an example, find a civil action moment, and make yourself a hero.
Most critically, however, is the question of whether these efforts will work. Ehrenberg admits it is a hard sell.
—Heather Thompson

January 17th, 2012
0

Medicine today is “very much siloed,” observes Daniel Kraft, MD in a TEDMED presentation. Typically, a hospital has separate departments for oncology, ophthalmology, hematology, urology, neurology, and so forth. This departmentalized structure inhibits dissemination of information across disciplines. In addition, medicine is somewhat insulated from the rapid clip of technological change seen in the consumer space.

But medicine is undergoing a revolution. As new technologies that are coming out, we have the ability to redefine medicine, Kraft says, not just to make it more cross-disciplinary, but to make it more reliant on science. “[Now] we don’t really practice evidence-based medicine. We practice reimbursement-based medicine,” he says. 

Here's a video of Kraft explaining his vision of the medical feature at TEDMED 2011:

...

January 17th, 2012
0

this week in devicesAmong stories in this edition of "This Week in Devices," Massdevice interviews Medtronic CEO Omar Ishrak and Scanadu views for the $10-million X Prize.

January 16th, 2012
0

News came out that John Edwards has a serious heart condition, and needs to have surgery next month. According to The Washington Post, Federal Judge Catherine Eagles said Edwards " had “three episodes” and indicated his condition could be life-threatening if left untreated."

The condition has caused the judge to delay Edwards' trial for six counts of felony and misdemeanors. He is accused of concealing nearly $1 million from wealthy donors and using it to help hide his pregnant mistress during his 2008 White House run. This is the second time the trial has been delayed.

The court...

January 13th, 2012
0
Alexis Lukianov
 Alex Lukianov

On January 10, PricewaterhouseCoopers, the California Healthcare Institute, and BayBio released early results of the California Biomedical Industry 2012 Report, which surveyed  biomedical industry CEOs.

Speaking at the announcement was a panel of three CEOs including Alex Lukianov, CEO of Nuvasive; Rick Winningham, CEO of Theravance; and Stephen Cary, PhD, CEO of Omniox. 

When asked what the broader trends were in terms of FDA, Lukianov cited the much-talked about slow down in device...

January 13th, 2012
0